cash position is atrocious to be frank.
The way I see it is that if they were of the mind to do a CR , it should have been done a few months ago. They have provided some detail in 4c about cash and what they are doing . They have made it clear that CR is the last option for them given the amt of dilution already.
Better yet , they have clear opportunities and key stakeholders right now , with the fallback of the R&D .
I bought in last Monday , but have the cash for a CR should that also eventuate. However I dont think shareholders will have that opportunity.
My bet - loan on commercial terms or convertible notes
BTW my missus and I call this one "fubar" but of course believe the opposite
